How much did Marinus Pharmaceuticals achieve in EBIT for the current year?
In the current year, Marinus Pharmaceuticals has achieved an EBIT of -108.28 M USD.
Marinus Pharmaceuticals EBIT 2024
Marinus Pharmaceuticals EBIT
-108.28 M USD
Marinus Pharmaceuticals Dividend yield
Ticker
MRNS
ISIN
US56854Q2003
WKN
A2QEUC
In 2024, Marinus Pharmaceuticals's EBIT was -108.28 M USD, a -17.65% increase from the -131.49 M USD EBIT recorded in the previous year.
The Marinus Pharmaceuticals EBIT history
| YEAR | EBIT (undefined USD) |
|---|---|
| 2030e | 550.99 |
| 2029e | 466.9 |
| 2028e | 173.33 |
| 2027e | 55.39 |
| 2026e | -27.3 |
| 2025e | -64.05 |
| 2024e | -108.28 |
| 2023 | -131.49 |
| 2022 | -112.79 |
| 2021 | -95.45 |
| 2020 | -67.94 |
| 2019 | -54.42 |
| 2018 | -37.18 |
| 2017 | -19.04 |
| 2016 | -28.24 |
| 2015 | -24.43 |
| 2014 | -11.92 |
| 2013 | -5.38 |
Marinus Pharmaceuticals Aktienanalyse
What does Marinus Pharmaceuticals do?
Marinus Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the development and commercialization of novel therapeutics for various neurological disorders. The company, headquartered in Radnor, Pennsylvania, USA, was founded in 2003 and has been listed on NASDAQ since 2012. Marinus Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Marinus Pharmaceuticals's EBIT
Marinus Pharmaceuticals's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Marinus Pharmaceuticals's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Marinus Pharmaceuticals's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Marinus Pharmaceuticals’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Marinus Pharmaceuticals Stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Marinus Pharmaceuticals.
How has the EBIT of Marinus Pharmaceuticals developed in recent years?
The EBIT of Marinus Pharmaceuticals has increased by -17.652% decreased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Marinus Pharmaceuticals?
The EBIT of Marinus Pharmaceuticals is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Marinus Pharmaceuticals pay?
Over the past 12 months, Marinus Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Marinus Pharmaceuticals is expected to pay a dividend of 0 USD.
What is the dividend yield of Marinus Pharmaceuticals?
The current dividend yield of Marinus Pharmaceuticals is .
When does Marinus Pharmaceuticals pay dividends?
Marinus Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Marinus Pharmaceuticals?
Marinus Pharmaceuticals paid dividends every year for the past 0 years.
What is the dividend of Marinus Pharmaceuticals?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Marinus Pharmaceuticals located?
Marinus Pharmaceuticals is assigned to the 'Health' sector.
Wann musste ich die Aktien von Marinus Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Marinus Pharmaceuticals from 5/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/24/2024.
When did Marinus Pharmaceuticals pay the last dividend?
The last dividend was paid out on 5/24/2024.
What was the dividend of Marinus Pharmaceuticals in the year 2023?
In the year 2023, Marinus Pharmaceuticals distributed 0 USD as dividends.
In which currency does Marinus Pharmaceuticals pay out the dividend?
The dividends of Marinus Pharmaceuticals are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Marinus Pharmaceuticals
Our stock analysis for Marinus Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Marinus Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Marinus Pharmaceuticals Revenue
- Marinus Pharmaceuticals Net Income
- Marinus Pharmaceuticals P/E
- Marinus Pharmaceuticals P/S
- Marinus Pharmaceuticals EBIT
- Marinus Pharmaceuticals Dividend
- Marinus Pharmaceuticals Stocks
- Marinus Pharmaceuticals Market capitalization
- Marinus Pharmaceuticals Debt
- Marinus Pharmaceuticals Liabilities
- Marinus Pharmaceuticals Equity
- Marinus Pharmaceuticals AAQS
- Marinus Pharmaceuticals Employees
- Marinus Pharmaceuticals ROE
- Marinus Pharmaceuticals ROA
- Marinus Pharmaceuticals ROCE
